HENDERSON, NV--(Marketwired - Nov 17, 2016) - United Health Products Inc. (OTCQB: UEEC) announced that it has granted Carney Export - Import the exclusive rights to distribute United Health Products Inc. HemoStyp® products to all markets in South Korea. Carney Export - Import's South Korean operations will be under the direction of David Champion. Mr. Champion is a former Marketing Director of Covidien, and a former Product Manager of Tyco for the Asian markets.
The company will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on November 21, 2016. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss the company's current events and insight to the 2017 business plan. The call in conference will be Monday, November 21 at 12:30 pm Eastern. To listen to the discussion:
1. Call your Dial-In Number: (712) 451-0011
2. Enter your Access Code: 291859. 1359 pin
Anyone who is interested and cannot access or attend the call can go to the company's website www.unitedhealthproductsinc.com and listen to the entire call which will posted as an audio file on Tuesday, November 22 by noon EST.
About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.